Severe Aortic Stenosis
AVA <1.0 cm², Mean grad ≥40, Vmax ≥4.0 m/s
Aortic Stenosis Management (ESC/EACTS 2025): Severe Aortic Stenosis → Symptomatic? → Intervention Recommended → Valve Selection - 2025 Update → TAVI Rec...
Pathway Overview
9 steps
9 total
AVA <1.0 cm², Mean grad ≥40, Vmax ≥4.0 m/s
Dyspnea, angina, syncope
Class I for symptomatic severe AS
Age and anatomy assessment
Age ≥70 + Tricuspid AV + TF access
Individualized factors
Follow-up per guidelines
Age <70 OR Bicuspid OR Non-TF
Consider intervention if:
2025 ESC/EACTS Guidelines for Valvular Heart Disease
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Contraindicated Populations
Applicable Regions
EU: ESC/EACTS 2025: TAVI age ≥70 (lowered from 75)
US: ACC/AHA Heart Team approach
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
The Aortic Stenosis Management (ESC/EACTS 2025) is a management clinical algorithm for Cardiology. It provides a structured decision tree to guide clinical decision-making, based on 2025 ESC/EACTS Guidelines for Valvular Heart Disease.
This algorithm is based on 2025 ESC/EACTS Guidelines for Valvular Heart Disease (DOI: 10.1093/eurheartj/ehab395).
Known limitations include: Age cutoffs are guides, not absolute; Bicuspid AS has different considerations; Heart Team decision always required. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the Aortic Stenosis Management (ESC/EACTS 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free